NovoCure
$12.86
142
+$0.67+5.5% Today
Statistics
Day High
12.91
Day Low
12.19
52W High
24.73
52W Low
10.7
Volume
85,485
Avg. Volume
1,523,008
Mkt Cap
1.44B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
26FebExpected
Expected EPS
-0.4125
Actual EPS
N/A
Financials
-27.86%Profit Margin
Unprofitable1.21BRevenue
-337.25MNet Income
Analyst Ratings
$28.50Average Price Target
The highest estimate is 39.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NVCR. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Intuitive Surgical
ISRG
Mkt Cap189.4B
Medtronic
MDT
Mkt Cap116.33B
Boston Scientific
BSX
Mkt Cap149.24B
Stryker
SYK
Mkt Cap136.19B
Abbvie
ABBV
Mkt Cap385.18B
Merck
MRK
Mkt Cap214.76B
Pfizer
PFE
Mkt Cap140.15B
Johnson & Johnson
JNJ
Mkt Cap455.04B
About
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Show more...
CEO
Mr. William F. Doyle
Employees
1488
Country
GB
ISIN
JE00BYSS4X48
Listings
0 Comments
Share your thoughts
FAQ
What is NovoCure stock price today?▼
The current price of NVCR is $12.86 USD — it has increased by +5.5% in the past 24 hours. Watch NovoCure stock price performance more closely on the chart.
What is NovoCure stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NovoCure stocks are traded under the ticker NVCR.
Is NovoCure stock price growing?▼
NVCR stock has fallen by -2.99% compared to the previous week, the month change is a -3.51% fall, over the last year NovoCure has showed a -46.69% decrease.
What is NovoCure market cap?▼
Today NovoCure has the market capitalization of 1.44B
When is the next NovoCure earnings date?▼
NovoCure is going to release the next earnings report on February 26, 2026.
What were NovoCure earnings last quarter?▼
NVCR earnings for the last quarter are -0.33 USD per share, whereas the estimation was -0.42 USD resulting in a +21.37% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is NovoCure revenue for the last year?▼
NovoCure revenue for the last year amounts to 1.21B USD.
What is NovoCure net income for the last year?▼
NVCR net income for the last year is -337.25M USD.
How many employees does NovoCure have?▼
As of February 03, 2026, the company has 1,488 employees.
In which sector is NovoCure located?▼
NovoCure operates in the Health Care sector.
When did NovoCure complete a stock split?▼
NovoCure has not had any recent stock splits.
Where is NovoCure headquartered?▼
NovoCure is headquartered in Baar, GB.